Aptevo Therapeutics Inc. Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aptevo Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aptevo Therapeutics Inc. for July 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 7,380 | 63,173 | 7,380 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 7,380 | 63,173 | 7,380 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 41.58 | 3,128 | 130,062 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 35.70 | 1,928 | 68,830 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 41.58 | 3,128 | 130,062 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 34.58 | 2,695 | 93,193 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 35.70 | 1,928 | 68,830 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 34.58 | 2,695 | 93,193 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 7,784 | 66,631 | 7,784 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 7,784 | 66,631 | 7,784 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 41.58 | 3,908 | 162,495 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 35.70 | 2,779 | 99,210 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 41.58 | 3,908 | 162,495 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 34.58 | 2,072 | 71,650 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 35.70 | 2,779 | 99,210 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 34.58 | 2,072 | 71,650 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | A | 8.56 | 6,423 | 54,981 | 6,423 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 41.16 | 5,357 | 220,494 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | A | 8.56 | 4,813 | 41,199 | 4,813 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | A | 8.56 | 16,625 | 142,310 | 16,625 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 21.28 | 10,828 | 230,420 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 43.82 | 10,828 | 474,483 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 30.10 | 5,414 | 162,961 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 27.44 | 5,414 | 148,560 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 41.16 | 14,319 | 589,370 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 25.20 | 2,545 | 64,134 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 |